Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): A randomised controlled trial

The Lancet

Volumn 379, Issue 9810, 2012, Pages 31-38

  Enden, Tone ^a   Haig, Ylva ^a,b   Kløw, Nils Einar ^a,b   Slagsvold, Carl Erik ^a   Sandvik, Leiv ^a,b   Ghanima, Waleed ^c   Hafsahl, Geir ^a   Holme, Pål Andre ^a   Holmen, Lars Olaf ^c   Njaastad, Anne Mette ^a   Sandbæk, Gunnar ^a,b   Sandset, Per Morten ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Østfold Hospital Trust Fredrikstad   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; DALTEPARIN; ENOXAPARIN; HEPARIN; WARFARIN;

ABDOMINAL WALL HEMATOMA; ADULT; AGED; ARTICLE; BLEEDING; CATHETER DIRECTED THROMBOLYSIS; COMPARTMENT SYNDROME; COMPRESSION GARMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HEMATOMA; HUMAN; ILEUS; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORWAY; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL NEUROPATHY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; SEPTICEMIA; STENT; THROMBUS ASPIRATION; TREATMENT DURATION; TREATMENT FAILURE; VASCULAR PATENCY; VENA CAVA FILTER;

EID: 84855477488     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61753-4     Document Type: Article

References (34)

1. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I-4-I-8.
2. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edn. Chest 2008; 133: 454S-545S. (Pubitemid 351892971)
3. Kahn SR. The post-thrombotic syndrome: progress and pitfalls. Br J Haematol 2006; 134: 357-65. (Pubitemid 44079549)
4. Guanella R, Ducruet T, Johri M, et al. Economic burden and cost determinants of deep vein thrombosis during two years following diagnosis: a prospective evaluation. J Thromb Haemost 2011; published online Sept 22. DOI:10.1111/j.1538-7836.2011.04516.x.
5. Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defi ned patient population in Sweden. Ann Intern Med 1997; 126: 454-57. (Pubitemid 27114474)
6. Kahn SR, Hirsch A, Shrier I. Eff ect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162: 1144-48. (Pubitemid 34522402)
7. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107: I-22-I-30.
8. Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141: 249-56.
9. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of eff ect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-62. (Pubitemid 27122458)
10. Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2004; 4: CD002783.
11. Enden T, Sandvik L, Klow NE, et al. Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis-the CaVenT Study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771). Am Heart J 2007; 154: 808-14. (Pubitemid 350017713)
12. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211: 39-49. (Pubitemid 29161732)
13. The Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695-702.
14. Enden T, Klow NE, Sandvik L, et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009; 7: 1268-75.
15. Villalta S, Bagatella P, Piccioli A, Lensing AW, Prins MH, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome. Haemostasis 1994; 24 (suppl 1): 157.
16. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C. Defi nition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 2009; 7: 879-83.
17. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319: 670-74. (Pubitemid 29423954)
18. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004; 164: 17-26. (Pubitemid 38067385)
19. Ghanima W, Kleven IW, Enden T, et al. Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis. J Thromb Haemost 2011; 9: 1261-63.
20. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698-707.
21. Stain M, Schonauer V, Minar E, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005; 3: 2671-76. (Pubitemid 41819794)
22. Arnesen H, Hoiseth A, Ly B. Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand 1982; 211: 65-68. (Pubitemid 12184325)
23. Schweizer J, Elix H, Altmann E, Hellner G, Forkmann L. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study. Vasa 1998; 27: 167-71. (Pubitemid 28364118)
24. Vedantham S, Grassi CJ, Ferral H, et al. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 2006; 17: 417-34.
25. Kahn SR. Measurement properties of the Villalta scale to defi ne and classify the severity of the post-thrombotic syndrome. J Thromb Haemost 2009; 7: 884-88.
26. Grunwald MR, Hofmann LV. Catheter-directed thrombolysis for the treatment of symptomatic deep vein thrombosis. Circulation 2004; 109: e10.
27. Sharifi M, Mehdipour M, Bay C, Smith G, Sharifi J. Endovenous therapy for deep venous thrombosis: the TORPEDO trial. Catheter Cardiovasc Interv 2010; 76: 316-25.
28. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2002; 24: 209-14. (Pubitemid 41085793)
29. Ly B, Njaastad AM, Sandbaek G, Solstrand R, Rosales A, Slagsvold CE. [Catheter-directed thrombolysis of iliofemoral venous thrombosis]. Tidsskr Nor Laegeforen 2004; 124: 478-80 (in Norwegian).
30. Broholm R, Sillesen H, Damsgaard MT, et al. Postthrombotic syndrome and quality of life in patients with iliofemoral venous thrombosis treated with catheter-directed thrombolysis. J Vasc Surg 2011; published online July 28. DOI:10.1016/j.jvs.2011.06.021.
31. Grunwald MR, Hofmann LV. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 2004; 15: 347-52. (Pubitemid 38451977)
32. Vedantham S. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2006; 17: 435-47.
33. Chung JW, Yoon CJ, Jung SI, et al. Acute iliofemoral deep vein thrombosis: evaluation of underlying anatomic abnormalities by spiral CT venography. J Vasc Interv Radiol 2004; 15: 249-56. (Pubitemid 38316446)
34. Kwak HS, Han YM, Lee YS, Jin GY, Chung GH. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol 2005; 16: 815-22.